Seminars in Nuclear Medicine
Volume 37, Issue 3 , Pages 173-184 , May 2007

Age-Related Structural and Metabolic Changes in the Pelvic Reproductive End Organs

References 

  1. Tenover JS. Declining testicular function in aging men. Int J Impot Res. 2003;4(suppl 15):S3–S8
  2. Liu PY, Wishart SM, Handelsman DJ. A double-blind, placebo-controlled, randomized clinical trial of recombinant human chorionic gonadotropin on muscle strength and physical function and activity in older men with partial age-related androgen deficiency. J Clin Endocrinol Metab. 2002;87:3125–3135
  3. Elmlinger MW, Kuhnel W, Wormstall H, et al. Reference intervals for testosterone, androstenedione and SHBG levels in healthy females and males from birth until old age. Clin Lab. 2005;51:625–632
  4. Elmlinger MW, Kuhnel W, Doller PC. Evaluation of direct and indirect markers to assess the androgen status in healthy males during aging. Clin Lab. 2006;52:491–496
  5. Sowers MR, Wilson AL, Karvonen-Gutierrez CA, et al. Sex steroid hormone pathway genes and health-related measures in women of 4 races/ethnicities: The Study of Women’s Health Across the Nation (SWAN). Am J Med. 2006;119:S103–S110
  6. Lerman H, Metser U, Grisaru D, et al. Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT. J Nucl Med. 2004;45:266–271
  7. Meldrum DR. Female reproductive aging—ovarian and uterine factors. Fertil Steril. 1993;59:1–5
  8. Magyar Z, Fel T. [Treatment of menopausal symptoms–review of the current literature]. Orv Hetil. 2006;147:879–885
  9. Wu CH. Current considerations of the menopause. Ann Clin Lab Sci. 1985;15:219–228
  10. Morse CA, Rice K. Memory after menopause: Preliminary considerations of hormone influence on cognitive functioning. Arch Womens Ment Health. 2005;8:155–162
  11. La Vecchia C. Sex hormones and cardiovascular risk. Hum Reprod. 1992;7:162–167
  12. Dalal D, Robbins JA. Management of hyperlipidemia in the elderly population: An evidence-based approach. South Med J. 2002;95:1255–1261
  13. Van Voorhis BJ. Genitourinary symptoms in the menopausal transition. Am J Med. 2005;118(suppl 12B):47–53
  14. Fitzgerald C, Zimon AE, Jones EE. Aging and reproductive potential in women. Yale J Biol Med. 1998;71:367–381
  15. Chakraborty TR, Gore AC. Aging-related changes in ovarian hormones, their receptors, and neuroendocrine function. Exp Biol Med (Maywood). 2004;229:977–987
  16. Kanaley JA, Sames C, Swisher L, et al. Abdominal fat distribution in pre- and postmenopausal women: The impact of physical activity, age, and menopausal status. Metabolism. 2001;50:976–982
  17. Gore AC, Oung T, Woller MJ. Age-related changes in hypothalamic gonadotropin-releasing hormone and N-methyl-D-aspartate receptor gene expression, and their regulation by oestrogen, in the female rat. J Neuroendocrinol. 2002;14:300–309
  18. Polo-Kantola P, Saaresranta T, Polo O. Aetiology and treatment of sleep disturbances during perimenopause and postmenopause. CNS Drugs. 2001;15:445–452
  19. Benitez del Castillo JM, del Rio T, Garcia-Sanchez J. Effects of estrogen use on lens transmittance in postmenopausal women. Ophthalmology. 1997;104:970–973
  20. Sipila S, Taaffe DR, Cheng S, et al. Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study. Clin Sci (Lond). 2001;101:147–157
  21. Taskin O, Gokdeniz R, Muderrisoglu H, et al. The effects of hormone replacement therapy on echocardiographic basic cardiac functions in postmenopausal women. Hum Reprod. 1998;13:2399–2401
  22. Boccardi M, Ghidoni R, Govoni S, et al. Effects of hormone therapy on brain morphology of healthy postmenopausal women: a Voxel-based morphometry study. Menopause. 2006;13:584–591
  23. Liang YL, Teede H, Shiel LM, et al. Effects of oestrogen and progesterone on age-related changes in arteries of postmenopausal women. Clin Exp Pharmacol Physiol. 1997;24:457–459
  24. Rice MM, Graves AB, McCurry SM, et al. Estrogen replacement therapy and cognitive function in postmenopausal women without dementia. Am J Med. 1997;103:26S–35S
  25. Straub RH, Hense HW, Andus T, et al. Hormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women: A population-based study. J Clin Endocrinol Metab. 2000;85:1340–1344
  26. Compton J, van Amelsvoort T, Murphy D. HRT and its effect on normal ageing of the brain and dementia. Br J Clin Pharmacol. 2001;52:647–653
  27. Hall JE, Lavoie HB, Marsh EE, et al. Decrease in gonadotropin-releasing hormone (GnRH) pulse frequency with aging in postmenopausal women. J Clin Endocrinol Metab. 2000;85:1794–1800
  28. Gill S, Sharpless JL, Rado K, et al. Evidence that GnRH decreases with gonadal steroid feedback but increases with age in postmenopausal women. J Clin Endocrinol Metab. 2002;87:2290–2296
  29. Reame NE, Kelche RP, Beitins IZ, et al. Age effects of follicle-stimulating hormone and pulsatile luteinizing hormone secretion across the menstrual cycle of premenopausal women. J Clin Endocrinol Metab. 1996;81:1512–1518
  30. Cano F, Simon C, Remohi J, et al. Effect of aging on the female reproductive system: Evidence for a role of uterine senescence in the decline in female fecundity. Fertil Steril. 1995;64:584–589
  31. Nalaboff KM, Pellerito JS, Ben-Levi E. Imaging the endometrium: disease and normal variants. Radiographics. 2001;21:1409–1424
  32. Hauth EA, Jaeger HJ, Libera H, et al: MR imaging of the uterus and cervix in healthy women: Determination of normal values. Eur Radiol, in press
  33. Herter LD, Golendziner E, Flores JA, et al. Ovarian and uterine sonography in healthy girls between 1 and 13 years old: Correlation of findings with age and pubertal status. AJR Am J Roentgenol. 2002;178:1531–1536
  34. Orbak Z, Sagsoz N, Alp H, et al. Pelvic ultrasound measurements in normal girls: Relation to puberty and sex hormone concentration. J Pediatr Endocrinol Metab. 1998;11:525–530
  35. Brown HK, Stoll BS, Nicosia SV, et al. Uterine junctional zone: correlation between histologic findings and MR imaging. Radiology. 1991;179:409–413
  36. Haynor DR, Mack LA, Soules MR, et al. Changing appearance of the normal uterus during the menstrual cycle: MR studies. Radiology. 1986;161:459–462
  37. Hoad CL, Raine-Fenning NJ, Fulford J, et al. Uterine tissue development in healthy women during the normal menstrual cycle and investigations with magnetic resonance imaging. Am J Obstet Gynecol. 2005;192:648–654
  38. Larson SM, Morris M, Gunther I, et al. Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer. J Nucl Med. 2004;45:366–373
  39. Mitchell DG, Schonholz L, Hilpert PL, et al. Zones of the uterus: discrepancy between US and MR images. Radiology. 1990;174:827–831
  40. Togashi K, Nakai A, Sugimura K. Anatomy and physiology of the female pelvis: MR imaging revisited. J Magn Reson Imaging. 2001;13:842–849
  41. Demas BE, Hricak H, Jaffe RB. Uterine MR imaging: Effects of hormonal stimulation. Radiology. 1986;159:123–126
  42. Goldstein SR, Nachtigall M, Snyder JR, et al. Endometrial assessment by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleeding. Am J Obstet Gynecol. 1990;163:119–123
  43. Karlsson B, Granberg S, Wikland M, et al. Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding–a Nordic multicenter study. Am J Obstet Gynecol. 1995;172:1488–1494
  44. Karlsson B, Granberg S, Hellberg P, et al. Comparative study of transvaginal sonography and hysteroscopy for the detection of pathologic endometrial lesions in women with postmenopausal bleeding. J Ultrasound Med. 1994;13:757–762
  45. Smith-Bindman R, Kerlikowske K, Feldstein VA, et al. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA. 1998;280:1510–1517
  46. Gupta JK, Chien PF, Voit D, et al. Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: A meta-analysis. Acta Obstet Gynecol Scand. 2002;81:799–816
  47. Grasel RP, Outwater EK, Siegelman ES, et al. Endometrial polyps: MR imaging features and distinction from endometrial carcinoma. Radiology. 2000;214:47–52
  48. Kido A, Togashi K, Koyama T, et al. Diffusely enlarged uterus: Evaluation with MR imaging. Radiographics. 2003;23:1423–1439
  49. Reinhold C, Tafazoli F, Mehio A, et al. Uterine adenomyosis: Endovaginal US and MR imaging features with histopathologic correlation. Radiographics. 1999;S147–S16019 Spec No
  50. Hricak H, Tscholakoff D, Heinrichs L, et al. Uterine leiomyomas: Correlation of MR, histopathologic findings, and symptoms. Radiology. 1986;158:385–391
  51. Merz E, Miric-Tesanic D, Bahlmann F, et al. Sonographic size of uterus and ovaries in pre- and postmenopausal women. Ultrasound Obstet Gynecol. 1996;7:38–42
  52. Nishizawa S, Inubushi M, Okada H. Physiological 18F-FDG uptake in the ovaries and uterus of healthy female volunteers. Eur J Nucl Med Mol Imaging. 2005;32:549–556
  53. Cohen HL, Tice HM, Mandel FS. Ovarian volumes measured by US: Bigger than we think. Radiology. 1990;177:189–192
  54. Haber HP, Mayer EI. Ultrasound evaluation of uterine and ovarian size from birth to puberty. Pediatr Radiol. 1994;24:11–13
  55. Giacobbe M, Pinto-Neto AM, Costa-Paiva LH, et al. Ovarian volume, age, and menopausal status. Menopause. 2004;11:180–185
  56. Goswamy RK, Campbell S, Royston JP, et al. Ovarian size in postmenopausal women. Br J Obstet Gynaecol. 1988;95:795–801
  57. Granberg S, Wikland M. A comparison between ultrasound and gynecologic examination for detection of enlarged ovaries in a group of women at risk for ovarian carcinoma. J Ultrasound Med. 1988;7:59–64
  58. Christensen JT, Boldsen J, Westergaard JG. Ovarian volume in gynecologically healthy women using no contraception, or using IUD or oral contraception. Acta Obstet Gynecol Scand. 1997;76:784–789
  59. Cottrill HM, Fitzcharles EK, Modesitt SC. Positron emission tomography in a premenopausal asymptomatic woman: A case report of increased ovarian uptake in a benign condition. Int J Gynecol Cancer. 2005;15:1127–1130
  60. Kim SK, Kang KW, Roh JW, et al. Incidental ovarian 18F-FDG accumulation on PET: Correlation with the menstrual cycle. Eur J Nucl Med Mol Imaging. 2005;32:757–763
  61. Short S, Hoskin P, Wong W. Ovulation and increased FDG uptake on PET: Potential for a false-positive result. Clin Nucl Med. 2005;30:707
  62. Zgliczynski S. [Menopause and andropause as a public health problem]. Pol Tyg Lek. 1995;50:3–4
  63. Wu CY, Yu TJ, Chen MJ. Age related testosterone level changes and male andropause syndrome. Chang Gung Med J. 2000;23:348–353
  64. Tenover JL. Male hormone replacement therapy including “andropause.”. Endocrinol Metab Clin North Am. 1998;27:969–987x
  65. Yialamas MA, Hayes FJ. Androgens and the ageing male and female. Best Pract Res Clin Endocrinol Metab. 2003;17:223–236
  66. Chanson P, Young J, Bry H. [Menopause and andropause]. Rev Prat. 2004;54:985–990
  67. Wyllie MG. ADAM and the andropause. BJU Int. 2003;91:883–884
  68. Morley JE, Korenman SG, Mooradian AD, et al. Sexual dysfunction in the elderly male. J Am Geriatr Soc. 1987;35:1014–1022
  69. Morley JE, Kaiser FE. Sexual function with advancing age. Med Clin North Am. 1989;73:1483–1495
  70. Forbes GB. Longitudinal changes in adult body composition: Influence of body weight. Appl Radiat Isot. 1998;49:571–573
  71. Stellato RK, Feldman HA, Hamdy O, et al. Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care. 2000;23:490–494
  72. Meier DE, Orwoll ES, Keenan EJ, et al. Marked decline in trabecular bone mineral content in healthy men with age: Lack of association with sex steroid levels. J Am Geriatr Soc. 1987;35:189–197
  73. Orwoll E, Ettinger M, Weiss S, et al. Alendronate for the treatment of osteoporosis in men. N Engl J Med. 2000;343:604–610
  74. Janowsky JS, Chavez B, Orwoll E. Sex steroids modify working memory. J Cogn Neurosci. 2000;12:407–414
  75. Wilson MM, Morley JE. Invited review: Aging and energy balance. J Appl Physiol. 2003;95:1728–1736
  76. Morley JE. Commentary: Geriatric future history. J Nutr Health Aging. 2006;10:431
  77. Morley JE. Andropause: Is it time for the geriatrician to treat it?. J Gerontol A Biol Sci Med Sci. 2001;56:M263–M265
  78. Morley JE. Anorexia, body composition, and ageing. Curr Opin Clin Nutr Metab Care. 2001;4:9–13
  79. Thompson CA, Shanafelt TD, Loprinzi CL. Andropause: Symptom management for prostate cancer patients treated with hormonal ablation. Oncologist. 2003;8:474–487
  80. Auger J, Jouannet P. Age and male fertility: biological factors. Rev Epidemiol Sante Publique. 2005;53 Spec No 2:2S25-35
  81. Johnson L. Evaluation of the human testis and its age-related dysfunction. Prog Clin Biol Res. 1989;302:35–60discussion 61-37
  82. Gray A, Feldman HA, McKinlay JB, et al. Age, disease, and changing sex hormone levels in middle-aged men: Results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 1991;73:1016–1025
  83. Gray DS, Gorzalka BB. Adrenal steroid interactions in female sexual behavior: A review. Psychoneuroendocrinology. 1980;5:157–175
  84. Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: Longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab. 2002;87:589–598
  85. Harman SM, Metter EJ, Tobin JD, et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men (Baltimore Longitudinal Study of Aging). J Clin Endocrinol Metab. 2001;86:724–731
  86. Morley JE, Kaiser FE, Sih R, et al. Testosterone and frailty. Clin Geriatr Med. 1997;13:685–695
  87. Carreau S, Bourguiba S, Marie E. Testicular and blood steroid levels in aged men. Reprod Biol. 2004;4:299–304
  88. Beres J, Papp G, Pazonyi I, et al. Testicular volume variations from 0 to 28 years of age. Int Urol Nephrol. 1989;21:159–167
  89. Chin T, Liu C, Wei C. Testicular volume in Taiwanese boys. Zhonghua Yi Xue Za Zhi (Taipei). 1998;61:29–33
  90. Matsuo N, Anzo M, Sato S, et al. Testicular volume in Japanese boys up to the age of 15 years. Eur J Pediatr. 2000;159:843–845
  91. Hamm B, Fobbe F. Maturation of the testis: ultrasound evaluation. Ultrasound Med Biol. 1995;21:143–147
  92. Paltiel HJ, Rupich RC, Babcock DS. Maturational changes in arterial impedance of the normal testis in boys: Doppler sonographic study. AJR Am J Roentgenol. 1994;163:1189–1193
  93. Ng KK, Donat R, Chan L, et al. Sperm output of older men. Hum Reprod. 2004;19:1811–1815
  94. Pasqualotto FF, Sobreiro BP, Hallak J, et al. Sperm concentration and normal sperm morphology decrease and follicle-stimulating hormone level increases with age. BJU Int. 2005;96:1087–1091
  95. Ford WC, North K, Taylor H, et al. The ALSPAC Study Team (Avon Longitudinal Study of Pregnancy and Childhood) Increasing paternal age is associated with delayed conception in a large population of fertile couples: evidence for declining fecundity in older men. Hum Reprod. 2000;15:1703–1708
  96. Kidd SA, Eskenazi B, Wyrobek AJ. Effects of male age on semen quality and fertility: A review of the literature. Fertil Steril. 2001;75:237–248
  97. Kuhnert B, Nieschlag E. Reproductive functions of the ageing male. Hum Reprod Update. 2004;10:327–339
  98. Eberling JL, Wu C, Haan MN, et al. Preliminary evidence that estrogen protects against age-related hippocampal atrophy. Neurobiol Aging. 2003;24:725–732
  99. Hassan MA, Killick SR. Effect of male age on fertility: evidence for the decline in male fertility with increasing age. Fertil Steril. 2003;79(suppl 3):1520–1527
  100. Homonnai ZT, Fainman N, David MP, et al. Semen quality and sex hormone pattern of 29 middle aged men. Andrologia. 1982;14:164–170
  101. Neaves WB, Johnson L, Porter JC, et al. Leydig cell numbers, daily sperm production, and serum gonadotropin levels in aging men. J Clin Endocrinol Metab. 1984;59:756–763
  102. Johnson L, Zane RS, Petty CS, et al. Quantification of the human Sertoli cell population: Its distribution, relation to germ cell numbers, and age-related decline. Biol Reprod. 1984;31:785–795
  103. Handelsman DJ, Staraj S. Testicular size: The effects of aging, malnutrition, and illness. J Androl. 1985;6:144–151
  104. Mahmoud AM, Goemaere S, El-Garem Y, et al. Testicular volume in relation to hormonal indices of gonadal function in community-dwelling elderly men. J Clin Endocrinol Metab. 2003;88:179–184
  105. Kosuda S, Fisher S, Kison PV, et al. Uptake of 2-deoxy-2-[18F]fluoro-D-glucose in the normal testis: retrospective PET study and animal experiment. Ann Nucl Med. 1997;11:195–199
  106. Wolf G, Aigner RM, Schwarz T, et al. Diagnosis of a contralateral second testicular carcinoma by F18-FDG PET. Onkologie. 2003;26:155–157
  107. Bosch JL, Hop WC, Niemer AQ, et al. Parameters of prostate volume and shape in a community based population of men 55 to 74 years old. J Urol. 1994;152:1501–1505
  108. Berry SJ, Coffey DS, Walsh PC, et al. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132:474–479
  109. Untergasser G, Madersbacher S, Berger P. Benign prostatic hyperplasia: Age-related tissue-remodeling. Exp Gerontol. 2005;40:121–128
  110. Sagel J, Distiller LA, Morley JE, et al. Myotonia dystrophica: Studies on gonadal function using luteinizing hormone-releasing hormone (LRH). J Clin Endocrinol Metab. 1975;40:1110–1113
  111. McNeal JE. The zonal anatomy of the prostate. Prostate. 1981;2:35–49
  112. Tolley DA, Castro JE. Hemospermia. Urology. 1975;6:331–332
  113. Rifkin MD, Dahnert W, Kurtz AB. State of the art: Endorectal sonography of the prostate gland. AJR Am J Roentgenol. 1990;154:691–700
  114. Torigian DA, Ramchandani P: Hematospermia: Imaging findings. Abdom Imaging, in press
  115. Arenas MI, Romo E, Royuela M, et al. Morphometric evaluation of the human prostate. Int J Androl. 2001;24:37–47
  116. Bartsch G, Rittmaster RS, Klocker H. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia. World J Urol. 2002;19:413–425
  117. Bostwick DG, Cooner WH, Denis L, et al. The association of benign prostatic hyperplasia and cancer of the prostate. Cancer. 1992;70:291–301
  118. Jungblut T, Aumuller G, Malek B, et al. Age-dependency and regional distribution of enkephalinergic nerves in human prostate. Urol Int. 1989;44:352–356
  119. Burnett AL, Maguire MP, Chamness SL, et al. Characterization and localization of nitric oxide synthase in the human prostate. Urology. 1995;45:435–439
  120. Crone JK, Burnett AL, Chamness SL, et al. Neuronal nitric oxide synthase in the canine prostate: Aging, sex steroid, and pathology correlations. J Androl. 1998;19:358–364
  121. Takeda M, Tang R, Shapiro E, et al. Effects of nitric oxide on human and canine prostates. Urology. 1995;45:440–446
  122. Roberts RO, Jacobson DJ, Rhodes T, et al. Serum sex hormones and measures of benign prostatic hyperplasia. Prostate. 2004;61:124–131
  123. Shibata Y, Ito K, Suzuki K, et al. Changes in the endocrine environment of the human prostate transition zone with aging: simultaneous quantitative analysis of prostatic sex steroids and comparison with human prostatic histological composition. Prostate. 2000;42:45–55
  124. Silver RI, Wiley EL, Thigpen AE, et al. Cell type specific expression of steroid 5 alpha-reductase 2. J Urol. 1994;152:438–442
  125. Allen KS, Kressel HY, Arger PH, et al. Age-related changes of the prostate: evaluation by MR imaging. AJR Am J Roentgenol. 1989;152:77–81
  126. Williams AM, Simon I, Landis PK, et al. Prostatic growth rate determined from MRI data: Age-related longitudinal changes. J Androl. 1999;20:474–480
  127. Vesely S, Knutson T, Damber JE, et al. Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms. Scand J Urol Nephrol. 2003;37:322–328
  128. Zackrisson B, Hugosson J, Aus G. Transrectal ultrasound anatomy of the prostate and seminal vesicles in healthy men. Scand J Urol Nephrol. 2000;34:175–180
  129. Jakobsen H, Torp-Pedersen S, Juul N. Ultrasonic evaluation of age-related human prostatic growth and development of benign prostatic hyperplasia. Scand J Urol Nephrol Suppl. 1988;107:26–31
  130. Xia SJ, Xu XX, Teng JB, et al. Characteristic pattern of human prostatic growth with age. Asian J Androl. 2002;4:269–271
  131. Jacobsen SJ, Jacobson DJ, Girman CJ, et al. Natural history of prostatism: risk factors for acute urinary retention. J Urol. 1997;158:481–487
  132. Morote J, Encabo G, Lopez M, et al. Prediction of prostate volume based on total and free serum prostate-specific antigen: Is it reliable?. Eur Urol. 2000;38:91–95
  133. Roehrborn CG, Boyle P, Gould AL, et al. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology. 1999;53:581–589
  134. Uygur MC, Erol D, Cetinkaya M, et al. The correlation between prostate-specific antigen and age (Analysis of prostate-specific antigen values from 4,846 Turkish men with symptomatic benign prostatic hyperplasia). Eur Urol. 1997;32:416–419
  135. Ezz el Din K, Kiemeney LA, de Wildt MJ, et al. Correlation between uroflowmetry, prostate volume, postvoid residue, and lower urinary tract symptoms as measured by the International Prostate Symptom Score. Urology. 1996;48:393–397

PII: S0001-2998(07)00020-7

doi: 10.1053/j.semnuclmed.2007.01.004

Seminars in Nuclear Medicine
Volume 37, Issue 3 , Pages 173-184 , May 2007

Article Tools

* Image Usage & Resolution